Meetings: Advisory Committee to Director,

[Federal Register: April 9, 1998 (Volume 63, Number 68)]

[Notices]

[Page 17427]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr09ap98-94]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Ethics Subcommittee of the Advisory Committee to the Director, Centers for Disease Control and Prevention: Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following subcommittee meeting.

Name: Ethics Subcommittee of the Advisory Committee to the Director, CDC.

Time and Date: 9 a.m.-3 p.m., April 27, 1998.

Place: CDC, Building 16, Room 5126, 1600 Clifton Road, NE, Atlanta, Georgia 30333.

Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 25 people.

Purpose: This subcommittee will anticipate, identify, and propose solutions to strategic and broad ethical issues facing CDC.

Matters To Be Discussed: Agenda items will include updates from the Associate Director for Science, Dixie E. Snider, M.D., followed by a discussion on issues surrounding the potential destruction of the smallpox virus, privacy and confidentiality of data collection, and scientific misconduct other than falsification, fabrication, and plagiarism.

Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Linda Kay McGowan, Acting Executive Secretary, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE, M/S D-24, Atlanta, Georgia 30333, telephone 404/ 639-7080.

Dated: April 2, 1998. Nancy C. Hirsch, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).

[FR Doc. 98-9332Filed4-8-98; 8:45 am]

BILLING CODE 4163-18-P